Field, J. J., Lin, G., Okam, M. M., Majerus, E., Keefer, J., Onyekwere, O., . . . Nathan, D. G. (2013). Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A(2A) receptor agonist regadenoson. American Society of Hematology.
Citação norma ChicagoField, Joshua J., et al. Sickle Cell Vaso-occlusion Causes Activation of INKT Cells That Is Decreased By the Adenosine A(2A) Receptor Agonist Regadenoson. American Society of Hematology, 2013.
ציטוט MLAField, Joshua J., et al. Sickle Cell Vaso-occlusion Causes Activation of INKT Cells That Is Decreased By the Adenosine A(2A) Receptor Agonist Regadenoson. American Society of Hematology, 2013.
אזהרה: ציטוטים אלה לעיתים לא מדויקים ב 100%.